Gabryelska Agata, Szmyd Bartosz, Szemraj Janusz, Stawski Robert, Sochal Marcin, Białasiewicz Piotr
Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, Poland.
Department of Medical Biochemistry, Medical University of Lodz, Poland.
J Clin Sleep Med. 2020 Oct 15;16(10):1761-1768. doi: 10.5664/jcsm.8682.
Obstructive sleep apnea (OSA) is a chronic condition that is characterized by recurrent pauses in breathing during sleep causing intermittent hypoxia. The main factor responsible for oxygen metabolism homeostasis is hypoxia-inducible factor 1 (HIF-1), comprised of 2 subunits: α (oxygen sensitive) and β. The aim of the study was to investigate the HIF-1α serum protein level and mRNA HIF-1α expression in patients with OSA and a healthy control group and determine their evening-morning variation and association with polysomnography parameters.
Eighty-four individuals were enrolled in the study. All patients underwent polysomnography examination and based on the results were divided into 2 groups: OSA group (n = 60) and control group (n = 24). Peripheral blood was collected in the evening before and in the morning after the polysomnography. HIF-1α expression was evaluated on protein in blood serum and mRNA level in peripheral blood leukocytes.
HIF-1α serum protein concentration was higher in patients with OSA compared with control patients in both the evening (1,490.1 vs. 727.0 pg/mL; P < .001) and the morning (1,368.9 vs. 702.1 pg/mL; P < .001) samples. There was no difference between evening and morning HIF-1α serum protein level in either group. No differences were observed in HIF-1α mRNA expression between the OSA and control group. Additionally, evening and morning HIF-1α serum protein level correlated with number of desaturations during sleep (r = .384, P < .001 and r = .433, P < .001, respectively).
Observed differences in HIF-1α serum protein level between the OSA and the control groups without difference between evening and morning measurements suggest chronic increase in this protein concentration by intermittent nocturnal hypoxia in OSA.
阻塞性睡眠呼吸暂停(OSA)是一种慢性疾病,其特征是睡眠期间反复出现呼吸暂停,导致间歇性缺氧。负责氧代谢稳态的主要因素是缺氧诱导因子1(HIF-1),它由两个亚基组成:α(对氧敏感)和β。本研究的目的是调查OSA患者和健康对照组中HIF-1α血清蛋白水平和mRNA HIF-1α表达情况,并确定其早晚变化以及与多导睡眠图参数的关联。
84名个体参与了本研究。所有患者均接受了多导睡眠图检查,并根据结果分为两组:OSA组(n = 60)和对照组(n = 24)。在多导睡眠图检查前一晚和检查后早晨采集外周血。评估血清中HIF-1α蛋白表达以及外周血白细胞中mRNA水平。
OSA患者的HIF-1α血清蛋白浓度在晚上(1490.1对727.0 pg/mL;P <.001)和早晨(1368.9对702.1 pg/mL;P <.001)样本中均高于对照组患者。两组中HIF-1α血清蛋白水平的早晚差异均无统计学意义。OSA组和对照组之间在HIF-1α mRNA表达上未观察到差异。此外,HIF-1α血清蛋白水平早晚均与睡眠期间的血氧饱和度下降次数相关(r分别为0.384,P <.001和0.433,P <.001)。
OSA组与对照组之间HIF-1α血清蛋白水平存在差异,且早晚测量无差异,这表明OSA患者夜间间歇性缺氧导致该蛋白浓度慢性升高。